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IN patients with advanced cancer, it is often not only difficult to prolong life,
but also to be certain whether treatment has done this. The relief of symptoms,
on the other hand, is easier to assess and in many cases not so difficult to accom-
plish.
Huggins and Scott (1945) described the effects of adrenalectomy in breast
cancer. This operation apparently prolonged life and often relieved suffering.
Soon, however, it became evident that this only occurred in a comparatively small
number of patients. The proportion of remissions obtained in the accounts of
published cases was never more than 40 per cent. The fact that so many patients
were unaffected by adrenalectomy was explained, however, by the suggestions
that the tumour was either not "hormone dependent ", or had become auto-
nomous. Alternatively, there may have been incomplete removal of the sources
of oestrogen production which may be either in accessory adrenal or ovarian
tissue. In all the patients who benefited from the operation, reactivation of the
disease occurred, in the majority ofcases, within two years, though, exceptionally,
a few remained well for periods as long as three or four years. The simplest
explanations for this reactivation were that there had been a continuation of
oestrogen secretion, or that the tumour was now being stimulated by pituitary
hormones, or possibly, that it had become completely autonomous.
When, therefore, Luft and Olivecrona (1952) described the results oftreatment
of cancer ofthe breast by hypophysectomy, it seemed possible that this treatment
might give better results than adrenalectomy. The more complete removal of
oestrogenic hormones, as well as prolactin and somatotrophin, should, theoretic-
ally, raise the remission rate very considerably. It was necessary to accept the
fact that adrenalectomy and hypophysectomy should only be undertaken in
advanced cases for palliation and not used in the early cases as a curative pro-
cedure. The aim oftreatment, in the advanced case, was to provide amelioration
of the disease, with relief of symptoms, for two or even three years. It was
decided, therefore, that only advanced cases, in whom all recognized palliative
treatment had already been carried out without success, should be treated by
pituitary ablation. These patients were specially selected for the trial of the
new method of treatment and selection was based, entirely, upon the fact that
all conventional methods had previously been tried.
Because the operation ofhypophysectomy is a difficult procedure and complete
hypophysectomy is difficult to obtain, it seemed reasonable to attempt to destroy
the pituitary by interstitial irradiation.W. P. GREENING ET AL.
History
The history of irradiation of the pituitary goes back thirty years or so.
Henderson (1938) in reporting on 338 cases of pituitary adenom%ta treated by
Cushing, described the implantation of radium, by the transphenoidal route, into
patients with basophil adenoma. In 1936, Lodge described an approach via the
orbit and ethmoid sinus to the sella turcica, in cases where the latter had become
grossly expanded by a tumour; after removal ofas much ofthe growth as possible,
radon seeds were implanted (Northfield, 1949). This same route is used by Bauer
(1956) to insert a cannula into the gland.
External irradiation with conventional X-rays produces little or no effect
upon this extremely radioresistant structure (Kelly et al., 1951), a high energy
proton beam can destroy the gland (Tobias et al., 1958).
Other methods such as electrocoagulation and the injection of chemical or
radioactive colloidal solutions, have also been tried. Electrocoagulation (Bauer,
1956) has not proved satisfactory because the electrode becomes covered with an
insulating layer of charred tissue and further destruction is thus prevented.
The injection into the gland of solutions of corrosive material, or of radioactive
materials is dangerous because of the impossibility of limiting the fluid to the
confines of the sella.
Radon seeds were the obvious choice, but experience has shown that their
penetrating gamma rays cause serious damage to the optic nerve which may
lead to total blindness in some cases (Forrest et al., 1956; Westminster Hospital
Report, 1956). It seemed reasonable, therefore, to try the effect of radioactive
gold grains (gold-198) and these were first inserted in February 1955. This
comparatively simple procedure from a technical point of view should be suitable
for use in a seriously ill patient. Since the expectation oflife following implanta-
tion would be unlikely to exceed three years, it would appear justifiable to accept
the possible occurrence of delayed effects of irradiation following damage to the
hypothalamus.
Rasmussen, Harper and Kennedy (1953) suggested from experimental evidence
that yttrium 90, a pure beta ray emitter, would be a suitable source for producing
localized destruction ofthe pituitary without damage to the surrounding structure.
Their experimental findings were confirmed by Yuhl et al. (1955) who introduced
yttrium pellets at craniotomy. Yttrium was therefore used for this purpose at
the Royal Marsden Hospital in July 1956.
Between February 1955 and March 1958, 100 patients with metastatic carci-
nonma of the breast were treated by implantation of the pituitary. Gold-198
was used in 54 cases and yttrium-90 in 36. The remaining 10 patients had first
one, and later, the other isotope implanted. Screened gold grains 2-5 mm. long,
0.8 mm. diameter and with a sheath of platinum 0.15 mm. thick were used at
first, but later, unscreened rods 5.0 mm. long, and 0.8 mm. diameter were im-
planted.
Gold-198 emits mainly gamma rays which are less penetrating than those
from radon and a small quantity of beta rays which do not penetrate, for the
EXPLANATION OF PLATE
FIG. 3. The pituitary occupies about three quarters of the depth of the fossa in this case.
FIG. 4.-Scaphoid anterior pituitary lying on the floor of the fossa.
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half life of the two isotopes is almost the same. Isodose curves (Fig. 1) show
the much more rapid fall offwith distance ofthe radiation from yttrium compared
with that from gold.
Method
The operation was always carried out under bacteriostatic and antibiotic
cover. This usually took the form of sulphadiazine, half a gramme six-hourly,
which was started on the day before operation and continued for a further five
days. In the earlier cases the nose was treated with streptomycin nasal drops,
90y
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FIG. 1.-Isodose curves for 90Y and 198Au. (Doses equated at 3 mm. from source.)
for two or three days before operation, but this was discontinued later in the
series. Cortisone 50 mg. daily was started on the day ofoperation; in the earlier
cases it was witheld until signs of adrenal insufficiency appeared but this was
considered to be an unnecessarily severe test on the patient, and was abandoned.
Antero-posterior and lateral radiographs ofthe skull were taken before operation.
The anaesthetic was administered by a cuffed endotracheal tube passed through
the mouth. The nose was packed before operation with gauze soaked in cocaine
and adrenalin. The rods of either 198Au or 90Y were inserted through a cannula
introduced into each nostril in turn. The position of the cannula was controlled
by visualization on an image intensifier, working in two planes.
Postoperative
The patient was nursed in a horizontal position for 12 hours and then allowed
to sit up. Cortisone was continued indefinitely and thyroid extract was given
when signs of thyroid deficiency appeared two to three months after operation.
46
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Complications
All patients developed headache but this was not usually severe and was
easily controlled by simple analgesics. In a few cases, persistent diabetes insipidus
made it necessary to give either pitressin tannate in oil or pitressin snuff. Bleeding
was a common occurrence but was not often severe, though two cases required
blood transfusion. Excessive bleeding was usually confined to those patients
in whom the base ofthe skull was grossly involved by metastatic tumour. Optic
atrophy occurred in 3 patients and must be assumed to be due to the implant,
but unfortunately this could not be confirmed as post-mortem examinations were
not carried out oni these particular patients. In one case, however, blindness was
discovered, at autopsy, to have been due to a metastasis in the optic nerve. The
most common, disastrous complication was rhinorrhoea followed by meningitis
which caused 10 deaths. Cerebrospinal fluid rhinorrhoea and meningitis, either
separately, or together, occurred in 21 patients of which 9 had 198Au and 12 had
90Y. Six patients developed meningitis without previous rhinorrhoea and 5
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FIG. 2. Onset of rhinorrhoea and meningitis following implant.
of these died. A striking feature of this complication was the variation in the
lapse oftime after implant before its occurrence. The diagram (Fig. 2) illustrating
this includes two patients suffering from a disease other than cancer ofthe breast.
Antibiotic cover, as long as the leakage persisted, was the only treatment
employed. Meningitis was extremely resistant to treatment and the clinical
course varied from acute fulminating to chronic. At post-mortem examination,
multiple adhesions with much fibrous exudate was commonly found and it was
not surprising, therefore, that antibiotics had little effect in these cases. There
are several possible causes of the cerebrospinal fluid leak. There was no cor-
relation between the activity of the rods and the development of the rhinorrhoea,
but there is no doubt that it occurs ifrods are placed high up anteriorly. In this
position they lie just under the diaphragma sellae and may cause it to necrose
(Forrest, 1959, personal communication). Rhinorrhoea can, however, occur
with properly placed rods and Forrest suggests that it is then due to overdosage,
but this does not explain the immediate leak of cerebrospinal fluid which we
have noticed on several occasions on the introduction of the cannula low down
near the floor of the fossa. The cause, therefore, probably lies in abnormal
anatomy and there are two variations from the normal which may be important.
Firstly, the depth of the fossa, as shown radiologically, does not necessarily
indicate the size of the gland which it contains (Fig. 3). The pituitary may
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sometimes consist of no more than a flattened disc (Fig. 4) lying on the floor,
and in such a case, the diaphragma is not stretched across the top but dips down
to be closely applied to the upper surface ofthe gland. It is easy to see, therefore,
that a rod placed in the middle of the fossa and judged to be in the middle of the
gland, might in fact be lying above the diaphragma in the subarachnoid space.
Secondly, the diaphragma sellae is often deficient. Mahmoud (1958) found this
to be so in forty of one hundred fossae examined at autopsy. Sometimes the
deficiency is quite large and it is in such cases that the subarachnoid space may
extend down into the fossa.
Results
The assessment of the results of hypophysectomy is difficult. In many
cases, the disease is apparently arrested no new lesions appearing, but without
any signs of healing of the original ones. In some patients marked subjective
improvement occurred with no evidence of any objective remission. It was
decided, therefore, only to assess those cases who have shown definite objective
remissions but this does not include '" arrest" of the disease. Many patients
die from their disease within a short time ofoperation and these cannot, therefore,
be assessed but in order to give an accurate picture of the series of 100 cases they
have been included, and no case has been removed from the series on the grounds
that it has been impossible to evaluate the patient, either because they have been
lost to follow-up, or, because they died too soon. All complications are included
and any death in which it is doubtful whether it was the result of the operation,
has, nevertheless, been included in the series. In addition to this, no patient
was refuised treatment, either because they were unfit for operation, or because
it was considered that the disease was too advanced. The results, therefore,
must be considered to be as complete as possible.
Only two patients are alive, although twelve (11-198Au, 1-90Y) had objective
evidence of regression and one of these survives 44 months after implant. The
remainder lived from periods ranging from 7 to 40 months, with an average
survival of 19.4 months. The survival of the 88 patients who did not respond
is shown (Fig. 5) 65 were dead in six months and 13 lived for less than one
month. The few who lived for relatively long periods reminid one how chronlic
this disease can be.
In 5 cases only was pituitary implantation performed as the first planned
treatment. Thirty-seven of the patients had had previous endocrine surgery,
either oophorectomy alone, or combined with adrenalectomy. None of them
showed improvement after pituitary implantation no matter what their response
to the previous operation had been. This is not surprising in those cases treated
by adrenalectomy, as response to pituitary ablation is unusual after this operation.
There was only one case that had relapsed after successful oophorectomy, and
pituitary implantation failed to induce further regression. It is obvious that no
reasonable comparison can be made ofthe results in this series with those obtained
by other methods of treatment.
Investigations
Apart from routine blood examinations and radiological surveys ofthe skeleton,
the following investigations were carried out on these patients:
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1. Urinary godadotrophin excretion.
2. Urinary oestrogen excretion.
3. Serum 17-ketosteroids.
4. Radioactive iodine uptake.
The urinary gonadotrophin and oestrogen assays were undertaken primarily
in order to see whether there was any correlation between the preoperative
levels and the results of treatment. It was also hoped to show whether there
had been complete pituitary destruction by comparing the postoperative findings
with those carried out before operation.
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FIG. 5. Survival after implant (non-responders) = 88 patients.
It is not the purpose of this paper to analyse in detail the results of I-hese
investigations, but some important points are noted. The estimation of gonado-
trophin excretion in the urine is the only satisfactory test available at present for
the measurement of pituitary function. The levels in premenopausal women
tend to be low. They rise after the menopause and the highest figures are usually
seen following castration. In any patient, however, whether premenopausal or
postmenopausal, there are wide variations from day to day and some solitary
tests are probably, therefore, valueless (Fig. 6). A fall to zero from a high value
before pituitary destruction indicates a considerable diminution of pituitary
function, but apart from a suggestion in those patients with moderately high levels
of gonadotrophin excretion before operation that a good result is probable, we
have not obtained any help from this estimation. The levels of oestrogen in
I
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the urine are subject to considerable daily variation and furthermore, the values
are influenced by the fact that many patients are having cortisone. We do not
find that preoperative or postoperative oestrogen assays are of value in the choice
of treatment.
The plasma 17-ketosteroid level usually falls after implantation but levels
obtained in all outpatients were so low that this did not seem to-be of any signi-
ficance.
Radioactive iodine uptake studies have shown evidence of diminished thyroid
finction and have occasionally been of value in assessing depressed pituitary
function in those patients whose preoperative gonadotrophin levels were low
and in whom, therefore, no fall could be recorded after implantation.
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FIG. 6. Post-menopausal woman, aged 53.
Pathology
The extent of destruction of the pituitary was estimated in 39 specimens
obtained at post-mortem and examined histologically. In 4 the gland was
totally destroyed-3 by 90Y (11.9, 12.8, 8-6 mc) and 1 by 198Au (80 mc). In 7
cases, the extent of destruction was estimated to be between 90 and 95 per cent,
and the activity of the rods ranged from 34 to 115 mc of 198Au and from 5.4 to
11l7 mc of 90Y. The smallest amount of 90Y known to have destroyed the
pituitary was 8.6 mc and the largest amount (11-7 mc) had not destroyed all the
gland. Thus, about 10 mc of 90Y should be sufficient to produce total necrosis
in most cases. In common with other workers, we have found that '98Au is
not efficient in producing total necrosis and in one case, 125 mc still left between
10 and 20 per cent of apparently viable cells.
We were able, in a few cases, to correlate the clinical response with the extent
of necrosis found at autopsy and the pre- and post-implantation urinary gonado-
trophin levels. In 2 of the 12 cases showing objective regression the destruc-
tion was 100 per cent in one and 95 per cent in the other and the gonadotrophin634 W. P. GREENING ET AL.
levels fell to zero in both cases. Among the patients who did not respond there
were 6 in which the extent of destruction was between 80 and 100 per cent and
in all these the gonadotrophin excretion fell to very low levels after implantation.
In the other 2 cases the amount of pituitary destroyed was small, 10 per cent
in one and 33 per cent in the other, yet, there was considerable fall in the gonado-
trophin excretion. One must, therefore, accept with caution a fall in urinary
gonadotrophin excretion as evidence of complete histological destruction of the
pituitary, although it probably reflects loss of function.
Discussion
Since there is considerable difference in the published figures given, both for
surgical hypophysectomy and irradiation hypophysectomy, the result in compar-
able series of patients from the point of view of the remission rate, mortality and
percentage of complications etc. are summarized in Table I. The number of
cases of breast cancer treated by surgical removal of the hypophysis is 342. The
average mortality is 7 per cent, the complication rate 15 per cent andthe remissions
46 per cent. In 675 cases treated by interstitial irradiation of the pituitary, the
mortality is 3 per cent, the complication rate 32 per cent and the average remission
is 29 per cent.
TABLE I.-Effects ofInterstitial Irradiation in Breast Cancer
Beneficial
Number Mortality Complications response
Authors of cases (%) (%) (%)
Fraser et al., 1959 . . 61 . 2 49 54
Ironside et al., 1959 . . 43 . - . 77 . 26
Greening et al. (this paper) 100 . 11 . 24 12
Forrest et al., 1959 . . 71 . 3 6 . 14
Bauer, 1956 . . 400 . 1 . 4 . 40
(less than) (approx.)
Total . . 675 . 3 32 29
Surgical removal
Ray and Pearson, 1959 . 109 . 3 12 . 50
(arrest 9%)
Kennedy et al., 1956 . 34 . 9 . 32 . 53
Luftet al.. 1958 . 59 12 - 26
(arrest 14%)
Radley-Smith, 1960 . 70 . 10 . 30 . 42
(arrest 10%)
Atkins et al., 1960 . . 70 . 3 . 10 . 60
Total . . . 342 . 7 . 15 . 46
Cerebrospinal fluid leakage is the main problem to be solved in order to make
interstitial implantation of the pituitary safe. Since the leakage usually occurs
when rods are placed high up in the fossa and rarely when they lie on the floor,
high placement ofthe rods must be avoided and in order to do so the fossa should
be approached horizontally. A horizontal approach via the nose is impossible
in many cases and septal deviation and enlarged turbinates add to the difficulties
of the operation. We have therefore changed over to the transethmoidal route
used by Bauer (1956), and a trial of this method is being undertaken.PITUITARY IRRADIATION FOR. BREAST CANCER 635
We also consider that the advantages of 90Y over 198Au are theoretical
rather than practical. 90Y with a short range and rapid fall off, requires to be
placed very accurately and since the rods are now implanted low in the fossa,
in all cases, it is preferable to use 198Au since it has a somewhat greater range
and will deliver an adequate dose to all parts of the gland. The amount of radia-
tion required is not known with any degree of certainty but for purpose of a
proposed trial we are using 50 mc of 198Au.
Summary
Between February 1955 and March 1958, initerstitial irradiation ofthe pituitary
was carried out in 100 cases, using either 198Au or 90y. When all treated patients
are included in the series and the strictest possible criteria used the remission
rate was 12 per cent, the mortality 11 per cent and the complication rate 24
per cent. The patients treated were those for whom no other method oftreatment
was available.
The operation itself is technically simple and in the majority of cases, no
more of an ordeal than ovariectomy.
It is suggested that this method of treatment is, in certain cases, well worth
continuing and that its usefulness could be increased considerably if the compli-
cation of rhinorrhoea were eliminated. Although it was originally undertaken
only in advanced cases of breast cancer, it has other spheres of usefulness and
may be helpful both in acromegaly and pituitary tumours.
A further trial of the method is being undertaken at present, using 198Au
grains implanted via the transethmoidal route.
We wish to thank all those authors who made their results available to us.
Our thanks are also due to the Departments of Medical Art and Photography
of the Royal Marsden Hospital.
Fig. 1, 2 and 3 (Ramsey, 1960) are reproduced by permnission of the Royal
Society of Medicine.
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